Biosimilar pharmaceuticals. Medical search. Frequent questions

Although biosimilars are not typically understood to be branded products, the consultation argues that they are subject to market competition, are less affected by price declines upon loss of exclusivity than non-biologics, and are required to be marketed as branded medicines by the Medicines and Healthcare products Regulatory Agency (MHRA). (pharmaceutical-technology.com)
Several biosimilars are already on the market in the UK over a range of therapy and disease areas (Figure 1) and their approvals have promised to deliver a more cost-effective solution for off-patent biologics, since they are typically cheaper than originator products and therefore allow the NHS to reinvest into innovative new treatments and patient care and therefore improve patient access. (pharmaceutical-technology.com)
The demand for biosimilars has considerably grown in recent years due to their close resemblance to biologics and usually reduced cost. (precedenceresearch.com)
Centus Biotherapeutics (Centus) founded in 2015 is a joint venture between AstraZeneca, a global pharmaceutical leader, and Fujifilm Kyowa Kirin Biologics, a Japanese biopharmaceutical company focused on biosimilar development. (fujifilmpharma.com)
With the unique coupling of world class biologics expertise, global commercial infrastructure and deep biosimilar development experience, Centus is well positioned to win the trust of doctors and serve the needs of patients worldwide. (fujifilmpharma.com)
By merging the technologies in advanced production, quality control and analysis which Fujifilm has developed over many years through its photographic film business, with the proprietary technologies and know-how which Kyowa Kirin has accumulated through its biopharmaceutical R&D and manufacturing, Fujifilm Kyowa Kirin Biologics creates revolutionary production processes and reduces costs for the production of biosimilars. (fujifilmpharma.com)
With this strategy, Fujifilm Kyowa Kirin Biologics aims to hold a leading position in the expanding biosimilar market. (fujifilmpharma.com)
The company's research and development activity in the biosimilar space has included a 2017 partnership with Adello Biologics (for the collaborative development of Neupogen and Neuasta biosimilars) and a 2018 partnership with mAbxience (for the development of Avastin biosimilars). (wikipedia.org)
The company said it plans to obtain approval for and launch four more biosimilars of major oncology and immunology biologics by 2020. (pharmaceuticalprocessingworld.com)
The Biologics Price Competition and Innovation Act (BPCIA), passed in 2010 as part of the Affordable Care Act, created an abbreviated approval pathway for biosimilars-versions of "originator" biologic drugs made by different manufacturers-to help address this issue. (nih.gov)
In March 2010, the Biologics Price Competition and Innovation Act, as part of the Affordable Care Act, included a standardized approval pathway for biologic, biosimilar, and interchangeable products. (pharmacytimes.com)
After a 10-year transition period, biosimilar products must now be approved under a biologics license application. (pharmacytimes.com)
However, biosimilars are not generic biologics because there can be no generic form of biologics due to the complex process of creating biologics. (kaloramainformation.com)

The pharma giant has recently launched Rituximab and Bevasizumab biosimilars, recommended in multiple indications under the brand names Ritucad™ and Bevaro ™ respectively. (cadilapharma.com)
According to NHS Improvement, uptake of etanercept, infliximab, and rituximab biosimilars alone has saved the NHS £210M ($267M) for FY2017-2018, and additional savings of £100M ($127M) could still be achieved from biosimilars alone this year with the commissioning of trastuzumab and adalimumab. (pharmaceutical-technology.com)
Sandoz receives approval in Europe for Rixathon (biosimilar rituximab) to treat blood cancers and immunological diseases. (pharmaceuticalprocessingworld.com)
Sandoz biosimilar rituximab has also been approved in the EU as Riximyo ® under a duplicate marketing authorization[8]. (pharmaceuticalprocessingworld.com)
Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab. (pharmaceuticalprocessingworld.com)
Target-directed development and preclinical characterization of the proposed biosimilar rituximab GP2013. (pharmaceuticalprocessingworld.com)
Pharmacokinetics, pharmacodynamics, safety and efficacy of proposed rituximab biosimilar (GP2013) vs. EU-Approved rituximab (rtx) in patients with rheumatoid arthritis: results from a randomized controlled trial (GP13-201) over 52 weeks. (pharmaceuticalprocessingworld.com)
This potential approval of Hyrimoz HCF builds on the already approved and well-established Sandoz biosimilar portfolio in immunology, including Erelzi ® (biosimilar etanercept), Zessly ® (biosimilar infliximab) and Rixathon ® (biosimilar rituximab, including rheumatoid arthritis indication). (globenewswire.com)

The global pharmaceutical stability and storage services industry revenue will gain around USD 5.4 billion by 2032 from USD 3.01 billion in 2022 and is growing at a remarkable CAGR of 6.02% from 2023 to 2032. (precedenceresearch.com)
In this interview from ASRS 2023, Drs. Ali Khan and Ravi Parikh discuss the potential cost implications of approving new anti-VEGF biosimilars. (aao.org)
Amgen's Amjevita is the first in a string of nine Humira biosimilars that are coming to market in 2023. (americanconference.com)
We are organizing the 12th Digital Pharmaceutical Innovations Exhibition & Congress from November 15-18, 2023 in Los Angeles, USA. (rarediseases.org)
Eight to 10 additional adalimumab biosimilars will potentially launch between July and December 2023. (pharmacytimes.com)
DCI's new 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors delves into the business operations and industry environment of the Big Three public drug wholesalers-AmerisourceBergen/Cencora, Cardinal Health, and McKesson. (prweb.com)
We project that drug distribution revenues for the Big Three public companies-AmerisourceBergen (Cencora), Cardinal Health, and McKesson-will reach $700 billion for 2023," says Drug Channels Institute CEO Adam J. Fein , Ph.D., the study's author and a widely regarded expert on pharmaceutical economics and the drug distribution system. (prweb.com)
Now in its 14th edition, The 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors offers 163 proprietary charts, exhibits, and data tables. (prweb.com)
SAN DIEGO, Sept. 12, 2023 (GLOBE NEWSWIRE) - Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors, announced today the pricing of an upsized underwritten public offering of 11,441,648 shares of its common stock at a price to the public of $30.59 per share. (itbusinessnet.com)

Sandoz now has four biosimilar medicines approved in Europe. (pharmaceuticalprocessingworld.com)
Precision for Medicine's Larry Blandford quoted in an article from Pharmaceutical Commerce magazine on a new biosimilar product from Novartis' Sandoz unit called Zarxio. (precisionmedicinegrp.com)
Basel, June 17, 2022 - Sandoz, a global leader in generic and biosimilar medicines, today announced that the European Medicines Agency (EMA) has accepted the application for high concentration formulation 100 mg/mL (HCF) of its biosimilar Hyrimoz ® (adalimumab) for regulatory review. (globenewswire.com)
With a strong portfolio of eight marketed biosimilars and a further 15+ in various stages of development, Sandoz has an unparalleled heritage and extensive expertise in the development, manufacturing and delivery of biosimilar medicines to patients and the healthcare community worldwide. (globenewswire.com)

The European Medicines Agency has acknowledged this issue and published specific guidelines regarding efficacy, safety and quality for the development of biosimilar products ( 3 ). (springer.com)
Over the past six decades, Cadila Pharmaceuticals has been engaged in development and manufacturing of affordable medicines and in making them available for patients across the world. (cadilapharma.com)
Teva Pharmaceutical Industries (Teva) discovers, develops, manufactures, and commercializes generic and specialty medicines. (pharmaceutical-technology.com)
This consultation opens only months after a new payment system for the statutory scheme was introduced in April, under the Branded Health Service Medicines (Costs) Regulations 2018, requiring pharmaceutical companies to pay 7.8% of their NHS product sales to the government and establish criteria for the maximum price per drug that companies can charge the NHS. (pharmaceutical-technology.com)
This has largely been due to a lack of understanding of the biosimilar medicines, in particular their safety, efficacy, and the policies and procedures on interchangeability or substitution. (pharmaceutical-technology.com)
It is envisaged that the proposed changes to the statutory scheme will not only render the projected NHS savings from biosimilars unachievable, but the additional financial constraints on manufacturers would also significantly impact market access of new biosimilars and therefore hinder patient access to these medicines. (pharmaceutical-technology.com)
Biosimilar drugs are drugs made from living cells and are relatively cheaper than generic medicines. (medindia.net)
Allowing prescription drugs to be purchased and imported from abroad has the potential to lower health care costs in the U.S. In the short term, patients could access some medicines at lower prices, since brand pharmaceuticals are generally more expensive in the United States than in other high-income countries, in part because some nations have taken steps to limit drug prices. (pewtrusts.org)
As patents on originator biologic medicines begin to expire, there are growing opportunities for biosimilars to enter the market at lower prices. (goodwinlaw.com)
These biosimilars are molecules highly similar to approved biologic medicines and are comprehensively developed and rigorously tested to ensure that efficacy and safety are similar to the reference product. (neurosciencecme.com)
In line with our corporate philosophy of "caring for life", we have entered into the biosimilars area, as a part of our passion and commitment to unlocking access to life-saving medicines for more patients. (fresenius-kabi.com)
By committing to bring biosimilar formulations such as Hyrimoz citrate-free HCF to patients, we are serving a critical need in expanding access to important medicines and fueling pharmaceutical innovation. (globenewswire.com)
Celltrion Healthcare has announced, in a Dec. 10, 2020 press release, that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for the marketing authorization of CT-P17-an adalimumab biosimilar. (pharmtech.com)
Despite all the efforts by the Ministry of Health to provide adequate and safe medicines, the Iraqi pharmaceuti- cal sector has several challenges, including inadequate budget allocated to the ministry, shortages in essential medicines, underutilization of electronic technologies in the management of regulation-related work, a large number of substandard and falsified medications in the private sector and a stagnant national pharmaceutical industry. (who.int)
The Directorate pharmaceutical products by the Iraqi Ministry of Health regulates the following health products: medicines, from registration and approval to post-marketing, assess biotherapeutics, vaccines, blood and blood components, the main challenges faced and make recommendations herbal and traditional medicines, food supplements, to tackle the issues. (who.int)
According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals (EMA/CHMP/SWP/4447/00), vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids proteins, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment. (janusinfo.se)

Revisiting Interchangeability: Does the Designation Benefit Biosimilars? (americanconference.com)

Now the exclusive patent for adalimumab has expired up to four biosimilars are expected to be available from December although the use of Humira may continue where clinically appropriate and where it is best value. (medscape.com)

2-5 Approved adalimumab biosimilars have consistently demonstrated these qualifications in clinical trials. (pharmacytimes.com)

On August 07, 2018, the Department of Health and Social Care (DoHSC) in the UK launched a consultation for proposed changes to the statutory scheme for pharmaceutical pricing which safeguards the financial position of the National Health Service (NHS) by imposing price controls on the costs of branded pharmaceuticals. (pharmaceutical-technology.com)
In 2018, Amneal Pharmaceuticals LLC merged with Impax Laboratories, Inc. to form Amneal Pharmaceuticals, Inc. Shares of newly public AMRX began trading on the NYSE on May 7, 2018. (wikipedia.org)
In 2018, Amneal Pharmaceuticals LLC merged with Impax Laboratories, Inc. to form Amneal Pharmaceuticals, Inc. The FTC described the merger as having a value of US$1.45 billion, and required the companies to divest several marketed products and development projects as a condition of the approval. (wikipedia.org)
The following is an illustration of the company's major mergers and acquisitions and historical predecessors: Amneal Pharmaceuticals, Inc. Amneal Pharmaceuticals (Merged 2018) Amneal Pharmaceuticals LLC Akyma Pharmaceuticals (Acq. (wikipedia.org)

Mumbai-based pharmaceutical company Cipla revealed that it has launched etanercept biosimilar drug in India to treat rheumatic disorders. (medindia.net)

To compare the quality of therapeutic erythropoietin (EPO) products, including two biosimilars, with respect to content, aggregation, isoform profile and potency. (springer.com)

As they are currently not listed as ABPI members, pipeline biosimilar developers targeting the UK market-such as Celltrion and Oncobiologics with adalimumab, Centus Biotherapeutics with bevacizumab, and DM Bio with ustekinumab-might well be affected should the changes go ahead. (pharmaceutical-technology.com)
Its pipeline includes Equidacent TM and Hulio ® , an adalimumab biosimilar (Product Code: FKB327), a drug used to treat a range of inflammatory diseases. (fujifilmpharma.com)

In the pharmaceutical, biotechnology , medical device , contract research, academic, and research sectors, these businesses vie for the services of qualified and seasoned scientists. (precedenceresearch.com)
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. (kaloramainformation.com)

Two original products, Eprex (epoetin alfa) and Dynepo (epoetin delta), and two biosimilar products, Binocrit (epoetin alfa) and Retacrit (epoetin zeta), were compared using (1) high performance size exclusion chromatography, (2) ELISA, (3) SDS-PAGE, (4) capillary zone electrophoresis and (5) in-vivo potency. (springer.com)
Of the tested products, the biosimilars have the same or even better quality as the originals. (springer.com)
Since 2007, the patent protection of Eprex has expired, and several biosimilar EPO products have entered the market. (springer.com)
Our aim was to compare the quality of four different EPO products: two original products, Eprex and Dynepo, and two Eprex biosimilars, Binocrit and Retacrit. (springer.com)
Four different EPO products, Eprex and Dynepo (original products), as well as Binocrit and Retacrit (biosimilars) were ordered via the Utrecht Medical Center pharmacy (Utrecht, the Netherlands) and stored according to manufacturers' specifications. (springer.com)
Teva also provides over-the-counter (OTC) products, besides active pharmaceutical ingredients (APIs). (pharmaceutical-technology.com)
At Leydig, we recognize that advancements in pharmaceuticals and biosimilars not only transform lives, but are also critical to the companies that devote millions of dollars and years of research in developing and bringing products to market. (leydig.com)
Leydig's considerable experience in representing pharmaceutical companies in the development and patenting of new products and treatment methods, as well as our long history of representing generic drug and biosimilar manufacturers, provides us with invaluable insights on all aspects of establishing, enforcing, and challenging patent rights across the globe. (leydig.com)
Through this partnership, the company will develop and manufacture reliable, high quality, cost-competitive biosimilar products and commercialize these products in a timely manner. (fujifilmpharma.com)
The company's Specialty Pharma Division is focused on the development of proprietary branded pharmaceutical products for the treatment of Central Nervous System disorders, Endocrine disorders and other select specialty segments. (wikipedia.org)
This division commercializes several branded pharmaceutical products, including Rytary, an extended release oral capsule formulation for the treatment of Parkinson's disease, Unithroid, for treatment of hypothyroidism, Emverm, for treatment of certain gastrointestinal infections, and Zomig Nasal Spray, for the acute treatment of migraines. (wikipedia.org)
All eyes are on these products as industry watchers ponder matters of exclusivity and market access to determine if biosimilars will be a successful venture in the US. (americanconference.com)
To ensure that clinicians buy into biosimilars, it is important that they understand how products are analysed and compared to the originator molecules. (europeanpharmaceuticalreview.com)
Biosimilar and interchangeable biosimilar products have the potential to reduce health care costs, similar to how generic drugs have reduced costs. (fda.gov)
Biosimilars marketed in the U.S. typically have launched with initial list prices 15% to 35% lower than comparative list prices of the reference products. (fda.gov)
The approval of Semglee (insulin glargine-yfgn) as biosimilar to, and interchangeable with Lantus (insulin glargine), is based on evidence that showed the products are highly similar and that there are no clinically meaningful differences between Semglee (insulin glargine-yfgn) and Lantus (insulin glargine) in terms of safety, purity and potency (safety and effectiveness). (fda.gov)
Neither can there be any guarantee that, if approved, such generic or biosimilar products will be approved for all indications included in the reference product's label. (globenewswire.com)
Our organisations have been working to provide patient information and support since 2014 and are familiar with the evidence to date which reinforces the fact that biosimilars are as safe and effective as the reference products. (medscape.com)
This report summarizes the regulations governing pharmaceutical products in Iraq, assesses the challenges faced and makes recommendations to tackle these issues. (who.int)

The Iraq pharmaceutical country profile 2020 , prepared by the Iraqi Ministry of Health in collaboration with the World Health Organization (WHO) in 2020, was the main source of information. (who.int)

Statistically, a significant association was observed between male and female pharmacists regarding the introduction of biosimilar medications in the Saudi Arabian healthcare setup. (jpionline.org)
However, as Dr. Parikh explains, current FDA regulations may mean that with the approval of new biosimilars for intraocular use, low-cost off-label options would become unavailable, and this could lead to significant cost increases for both patients and the healthcare system. (aao.org)
This unique, encyclopedic resource analyzes the crucial healthcare trends that will affect wholesale distribution of prescription pharmaceuticals. (prweb.com)
It remains the most comprehensive resource for analyzing the pharmaceutical distribution industry's economics, market structure, growth rates, forces of change, and interactions within the U.S. healthcare system. (prweb.com)
Providing affordable and high-quality healthcare to patients coping with chronic diseases is an integral part of Fresenius Kabi's purpose, and this is demonstrated by our long-term commitment towards developing a comprehensive portfolio of biosimilars. (fresenius-kabi.com)
Celltrion Healthcare has announced that EMA's CHMP has issued a positive opinion for the marketing authorization of CT-P17-an adalimumab biosimilar. (pharmtech.com)
If CT-P17 receives approval by the EC, Celltrion will be the first company to introduce an adalimumab biosimilar with high concentration and citrate-free formulation," said HoUng Kim, head of Medical and Marketing Division at Celltrion Healthcare, in the press release. (pharmtech.com)
Federal regulators have permitted the first "biosimilar" drug to be sold in the U.S. under a program intended to branch a new market of lower-cost substitutes to some of the most expensive treatments in healthcare. (medgadget.com)

D. commented, "We are happy to receive a positive CHMP opinion toward the approval of Equidacent TM , our bevacizumab biosimilar. (fujifilmpharma.com)
D. said, "I am delighted that CHMP decided to recommend the approval of the proposed biosimilar bevacizumab. (fujifilmpharma.com)

U.S. spending on pharmaceuticals exceeded $450 billion in 2016. (pewtrusts.org)
FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched. (pharmacytimes.com)
In March 2016, Novartis cancer drug gets FDA's principal 'biosimilar' affirmation. (medgadget.com)

The FDA's high standards for approval mean health care professionals and patients can be confident in the safety and effectiveness of an interchangeable biosimilar product, just as they would for the reference product. (fda.gov)

1 This abbreviated approval pathway for biosimilars does not routinely require clinical studies to reestablish efficacy and safety like the comprehensive new drug applications that were previously required. (pharmacytimes.com)

In December 2019, Amneal announced it had entered into an agreement to acquire a majority interest in AvKARE, a private label provider of generic pharmaceuticals in the US federal agency sector. (wikipedia.org)
18/07/2019: Pharegis implemented optimized procedures for state registration of pharmaceuticals in Eurasian Economic Union. (pharegis.com)
Biosimilar Market Trends 2019 is designed to provide a snapshot of issues and trends that are affecting the biosimilar market. (kaloramainformation.com)

Unfortunately, both clinicians and patients lack knowledge of biosimilar efficacy and safety, which leads to fewer clinicians prescribing them and patients experiencing feelings of uncertainty and ungrounded negative perceptions toward receiving biosimilars. (neurosciencecme.com)
This CME Outfitters OnDemand symposium from the Crohn's & Colitis Congress 2022 features an expert panel discussion that defines biosimilar terminology, presents clinical trial data and real-world evidence on the efficacy and safety of biosimilars, and details team-based strategies for enhancing patient-clinician shared decision-making (SDM) regarding the use of biosimilars. (neurosciencecme.com)
Assess the efficacy and safety of biosimilars via clinical trial data and real-world evidence in regard to treatment selection for patients with IBD. (neurosciencecme.com)

Ahmedabad-based Cadila Pharmaceuticals Limited has announced the launch of NuPTH an Osteoporosis biosimilar of Forteo in India. (cadilapharma.com)
Cadila Pharmaceuticals Ltd. ( www.cadilapharma.com ) is one of the largest privately-held pharmaceutical companies of India. (cadilapharma.com)
The pharmaceutical industry in this area is expanding at the fastest rate in the entire globe due to the existence of China, India, and Japan. (precedenceresearch.com)

Denosumab biosimilar is under clinical development by Teva Pharmaceutical Industries and currently in Phase III for Post Menopausal Osteoporosis. (pharmaceutical-technology.com)
Denosumab biosimilar (TVB-009) is under development for treatment of post menopausal osteoporosis. (pharmaceutical-technology.com)
In recent years, the pharmaceutical business has significantly increased the amount invested in research and development. (precedenceresearch.com)
Biosimilar Analytical Development in Sun Pharmaceutical Inds. (pharmaguideline.com)
Manager / Sr Manager - Biosimilar Analytical Development in Sun Pharmaceutical Inds. (pharmaguideline.com)
Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment. (precisionmedicinegrp.com)
Generic and biosimilar manufacturers, or drug developers, report that they have been unable to purchase samples of innovator drugs for their product development. (pewtrusts.org)
Dr Fraser Cummings and Jonathan Sweeting discussed this issue at a recent virtual roundtable event, where they highlighted the complexities of biosimilar development pathways and approval processes. (europeanpharmaceuticalreview.com)
Bringing a biosimilar from early development to market is a risky endeavour say Magnus Franzen (left) and Chris Isler, biosimilar experts at PA Consulting Group. (europeanpharmaceuticalreview.com)
Crinetics Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors. (itbusinessnet.com)

Rani Therapeutics has expanded its collaboration with Celltrion for developing RT-105, an orally administered adalimumab biosimilar. (pharmaceutical-business-review.com)
Under a new license and supply agreement, Celltrion will supply adalimumab biosimilar drug substance CT-P17 that is required for RT-105. (pharmaceutical-business-review.com)

Both actions have contributed to frequent confidential settlements between originator and biosimilar manufacturers that have delayed the availability of biosimilars. (nih.gov)
At least 80% of existing patients should be switched to the best value biologic (be it the originator or a biosimilar) within 12 months. (medscape.com)

Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. (wikipedia.org)
Amneal Pharmaceuticals was founded in 2002 by brothers Chirag and Chintu Patel. (wikipedia.org)

Biosimilars are attempted copies of the original product, but due to the complex structure and intricate manufacturing processes of protein drugs, they are only similar to the original product ( 1 , 2 ). (springer.com)
For decades, Leydig has paved the way for pharmaceutical companies to obtain approval for generic versions of branded drugs ranging from niche-market drugs to blockbusters. (leydig.com)
Ribavirin is a chemically derived pharmaceutical and belongs to a class of drugs called nucleoside analogues. (pharmaceutical-business-review.com)
US pharmaceutical giant Pfizer will expand its line of drugs and therapies with the takeover of $17 billion Hospira. (medindia.net)
Competition from generic drugs can significantly reduce spending on pharmaceuticals. (pewtrusts.org)
Biosimilars of provider-administered specialty drugs are now an important source of profits for wholesalers and specialty distributors," Fein adds. (prweb.com)

The Forteo biosimilar is used for treatment of osteoporosis and in patients with increased risk of fracture. (cadilapharma.com)
The biosimilar NuPTH aims to be a cost effective solution for patients and will be sold as an easy to use, pre-filled disposable pen," shared Amit Ajmera, Vice President, Cadila Pharmaceuticals Limited. (cadilapharma.com)
We will continue our efforts to bring high quality and affordable biosimilars to patients throughout European countries. (fujifilmpharma.com)
With patients and taxpayers shouldering a large portion of this financial burden, lawmakers have considered a range of policies to address the rising cost of pharmaceuticals. (pewtrusts.org)
Today, the U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus. (fda.gov)
9 out of 10 new patients should be started on the best value medicine within 3 months of a biosimilar launch. (medscape.com)
Andrew Davies, NHS Improvement's director of hospital pharmacy, said: 'The launch of biosimilar adalimumab will be the fifth major class of biosimilar launched for wider NHS use, and preparations have been put in place to make sure that more patients are able to receive this treatment as quickly as possible. (medscape.com)
The introduction of biosimilars for adalimumab brings opportunities for both patients and the NHS. (medscape.com)
RÉSUMÉ La présente étude a examiné les connaissances et la compréhension actuelles des patients en matière de substitution par des génériques. (who.int)
À notre avis, la substitution par des génériques ne doit pas être mise en œuvre de manière aléatoire en raison de l'incertitude et des faibles connaissances des patients. (who.int)
Though their primary missions are to focus attention on the needs of patients with a particular disease - such as arthritis, heart disease or various cancers - some groups effectively supplement the work lobbyists perform, providing patients to testify on Capitol Hill and organizing letter-writing and social media campaigns that are beneficial to pharmaceutical companies. (medscape.com)

The positive opinion, which has been based on Phase I/III study data assessing the equivalence of the biosimilar to the reference product, will move forward to the European Commission (EC) for review. (pharmtech.com)

Despite this huge economic potential and the commissioning framework for biosimilars published by NHS England as well as recommendations by National Institute for Health and Care Excellence (NICE) to increase their use, their uptake in the UK has been reported as highly variable and lower than expected by several research reports. (pharmaceutical-technology.com)

American drug pharmaceutical firm Mylan announced the launch of its breast cancer drug through its Indian subsidiary in the country. (medindia.net)

The lack of qualified experts in this area is a result of the pharmaceutical industry's growth toward innovative molecular structures and methods of action. (precedenceresearch.com)
The database explores only a slice of the pharmaceutical industry's giving overall and will be expanded with more companies and groups over time. (medscape.com)

Regeneron Pharmaceuticals (Grant Support). (aao.org)

Valtropin® is Biopartners' biosimilar rhGH for the treatment of growth hormone deficiency and Turner's Syndrome. (pharmaceutical-business-review.com)

To create and verify stability-indicating techniques and carry out analysis of leachable compounds that move from pharmaceutical packaging into the product, stability testing can present significant analytical challenges. (precedenceresearch.com)
3 is the best chance to build a network with scientists, researchers, pharmacologists, Experts, Practitioners, academicians, professors and students from across the world and discuss best practices, share the vision of therapeutics and the latest trends and innovations in the world pharmaceuticals, opportunities and challenges. (rarediseases.org)

The degree of similarity between the original product and its biosimilar is more difficult to assess than between an original small molecule pharmaceutical and its generic version. (springer.com)
While supplements, help in prevention of osteoporosis, the biosimilar product is the only agent which helps build new bones. (cadilapharma.com)
This scheme is applicable only to pharmaceutical companies that are not registered under the Pharmaceutical Price Regulation Scheme (PPRS) 2014, a voluntary scheme agreed to between members of the Association of the British Pharmaceutical Industry (ABPI) and the DoHSC, which regulates the profit pharmaceutical companies can make on NHS product sales. (pharmaceutical-technology.com)
After the 2007 acquisition of Akyma Pharmaceuticals, a Glasgow, Kentucky-based regional distributor, Amneal launched its own product label. (wikipedia.org)
Reverse payment agreements, also known as "pay-for-delay" deals, are settlements that involve a brand pharmaceutical manufacturer paying one or more potential generic competitors to resolve patent infringement lawsuits and agree upon a date by which the generic product can come to market. (pewtrusts.org)
Instead, the manufacturer must demonstrate the proposed product is biosimilar to an FDA-approved reference product using comparative testing of safety, purity, and potency. (pharmacytimes.com)
Biosimilars cannot automatically be substituted for a reference product at the pharmacist level without prescriber permission unless the biosimilar has been granted interchangeable status (subject to state laws). (pharmacytimes.com)
Semglee (insulin glargine-yfgn) is both biosimilar to, and interchangeable with (can be substituted for), its reference product Lantus (insulin glargine), a long-acting insulin analog. (fda.gov)
Semglee (insulin glargine-yfgn) is the first interchangeable biosimilar product approved in the U.S. for the treatment of diabetes. (fda.gov)
A biosimilar is a biological product that is highly similar to, and has no clinically meaningful differences from, a biological product already approved by the FDA (also called the reference product). (fda.gov)
This means you can expect the same safety and effectiveness from the biosimilar as you would the reference product. (fda.gov)
An interchangeable biosimilar product may be substituted for the reference product without the intervention of the prescriber. (fda.gov)
A biosimilar is a biologic product that is highly similar to another approved biologic product, known as "reference product", and has no clinically meaningful differences in terms of effectiveness, safety or exposure from the reference product. (fresenius-kabi.com)
Fresenius Kabi applies the same high-quality standards in developing and producing biosimilars as is required for the reference product. (fresenius-kabi.com)
Pharmaceutical companies currently have until October 22nd to hand in documentation about their product and its price. (medscape.com)
Two further biosimilars are expected to become available in the UK next year, Cyltezo (Boehringer Ingelheim) and a product by Fresenius Kabi. (medscape.com)
XM02 is a biosimilar product of existing G-CSF. (janusinfo.se)

To facilitate more timely biosimilar entry, policy makers should consider limits on patent prosecution, compulsory public patent listing, and enhanced antitrust enforcement. (nih.gov)

Read the European Pharmaceutical Review by-line here . (goodwinlaw.com)

A significant part of our pharmaceutical practice involves representing clients in the generic drug industry in matters arising under the Hatch-Waxman Act. (leydig.com)
Remsima could soon become the second biosimilar drug to be approved by the U.S. Food and Drug Administration. (medindia.net)
Remsima is a biosimilar drug of Johnson & Johnson's Remicade. (medindia.net)
Now the FDA panel has voted 21-3 for the biosimilar drug, supporting its approval on April 6. (medindia.net)
But the FDA has recommended the biosimilar drug to be approved for treating autoimmune diseases similar to that of the drug Remicade. (medindia.net)
The first biosimilar drug approved by the FDA was Zarzio. (medindia.net)
Drug Channels Institute is a leading source of industry research about pharmaceutical economics and the drug distribution system. (prweb.com)

Therefore, clinical data acquired from the original biological cannot necessarily be extended to its biosimilar(s). (springer.com)

Fujifilm") and Kyowa Kirin Co., Ltd. (President and CEO: Masashi Miyamoto, "Kyowa Kirin") on March 27, 2012 as a company for developing, manufacturing, and marketing biosimilars. (fujifilmpharma.com)
These patents were identified from disclosures by the brand-side company, in response to a potential biosimilar seeking to launch. (drugpatentwatch.com)

Chemicals and Drugs4

Analytical, Diagnostic and Therapeutic Techniques and Equipment1

Phenomena and Processes1

Anthropology, Education, Sociology and Social Phenomena4

Technology, Industry, Agriculture1

Health Care3

Geographicals1

Biologics13

Rituximab8

20239

Sandoz4

Medicines16

Interchangeability1

Humira1

Adalimumab biosimilars1

20184

Etanercept1

Therapeutic1

Pipeline2

Biotechnology2

Products19

20201

Healthcare8

CHMP2

20163

FDA's1

Approval pathway1

20193

Efficacy and safety3

India3

Development10

Celltrion2

Originator2

Amneal Pharmaceuticals2

Drugs6

Patients11

Assessing1

Uptake1

Mylan1

Industry's2

Regeneron Pharmaceuticals1

Growth1

Challenges2

Product17

Timely1

European Pharmaceutical Review1

Drug7

Biological1

Company2